Global Plasma Protein Therapeutics Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Plasma Protein Therapeutics market size is predicted to grow from US$ 36930 million in 2025 to US$ 58220 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The plasma protein therapeutics market is driven by the increasing prevalence of rare and chronic diseases such as hemophilia, primary immunodeficiency, and autoimmune disorders, which require life-saving plasma-derived treatments. Advances in plasma fractionation techniques and the growing demand for immunoglobulins, albumin, and clotting factors are further fueling market growth. Additionally, improvements in diagnostic technologies have led to earlier detection and treatment of these conditions, expanding the patient pool for plasma protein therapies. Increasing awareness and access to these treatments in developing regions are also contributing to market expansion.A significant challenge in the plasma protein therapeutics market is the limited availability of plasma due to the complex and time-consuming process of plasma collection and fractionation. This often results in supply shortages, which can affect patient access to essential therapies. The high cost of plasma protein therapies, due to the labor-intensive production process and stringent regulatory requirements, also poses a barrier to treatment affordability. Furthermore, the market faces increasing competition from recombinant therapies, which are being developed as alternatives to plasma-derived products, potentially impacting market share.
Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market. North America is the major region of the global market, which takes about 40% market share.
LP Information, Inc. (LPI) ' newest research report, the “Plasma Protein Therapeutics Industry Forecast” looks at past sales and reviews total world Plasma Protein Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Plasma Protein Therapeutics sales for 2025 through 2031. With Plasma Protein Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma Protein Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Plasma Protein Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasma Protein Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasma Protein Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma Protein Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma Protein Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Protein Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Plasma Protein Therapeutics market?
What factors are driving Plasma Protein Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Protein Therapeutics market opportunities vary by end market size?
How does Plasma Protein Therapeutics break out by Type, by Application?
The global Plasma Protein Therapeutics market size is predicted to grow from US$ 36930 million in 2025 to US$ 58220 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The plasma protein therapeutics market is driven by the increasing prevalence of rare and chronic diseases such as hemophilia, primary immunodeficiency, and autoimmune disorders, which require life-saving plasma-derived treatments. Advances in plasma fractionation techniques and the growing demand for immunoglobulins, albumin, and clotting factors are further fueling market growth. Additionally, improvements in diagnostic technologies have led to earlier detection and treatment of these conditions, expanding the patient pool for plasma protein therapies. Increasing awareness and access to these treatments in developing regions are also contributing to market expansion.A significant challenge in the plasma protein therapeutics market is the limited availability of plasma due to the complex and time-consuming process of plasma collection and fractionation. This often results in supply shortages, which can affect patient access to essential therapies. The high cost of plasma protein therapies, due to the labor-intensive production process and stringent regulatory requirements, also poses a barrier to treatment affordability. Furthermore, the market faces increasing competition from recombinant therapies, which are being developed as alternatives to plasma-derived products, potentially impacting market share.
Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market. North America is the major region of the global market, which takes about 40% market share.
LP Information, Inc. (LPI) ' newest research report, the “Plasma Protein Therapeutics Industry Forecast” looks at past sales and reviews total world Plasma Protein Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Plasma Protein Therapeutics sales for 2025 through 2031. With Plasma Protein Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma Protein Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Plasma Protein Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasma Protein Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasma Protein Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma Protein Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma Protein Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Protein Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
- Hemophilia
- PID
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
What is the 10-year outlook for the global Plasma Protein Therapeutics market?
What factors are driving Plasma Protein Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Protein Therapeutics market opportunities vary by end market size?
How does Plasma Protein Therapeutics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma Protein Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Plasma Protein Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Plasma Protein Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Plasma Protein Therapeutics Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Others
2.3 Plasma Protein Therapeutics Sales by Type
2.3.1 Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2020-2025)
2.4 Plasma Protein Therapeutics Segment by Application
2.4.1 Hemophilia
2.4.2 PID
2.4.3 Others
2.5 Plasma Protein Therapeutics Sales by Application
2.5.1 Global Plasma Protein Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Plasma Protein Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Plasma Protein Therapeutics Breakdown Data by Company
3.1.1 Global Plasma Protein Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Plasma Protein Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Plasma Protein Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Plasma Protein Therapeutics Sale Price by Company
3.4 Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Protein Therapeutics Product Location Distribution
3.4.2 Players Plasma Protein Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Plasma Protein Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Plasma Protein Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Plasma Protein Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Plasma Protein Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Plasma Protein Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Plasma Protein Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Plasma Protein Therapeutics Sales Growth
4.4 APAC Plasma Protein Therapeutics Sales Growth
4.5 Europe Plasma Protein Therapeutics Sales Growth
4.6 Middle East & Africa Plasma Protein Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Plasma Protein Therapeutics Sales by Country
5.1.1 Americas Plasma Protein Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Plasma Protein Therapeutics Revenue by Country (2020-2025)
5.2 Americas Plasma Protein Therapeutics Sales by Type (2020-2025)
5.3 Americas Plasma Protein Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Protein Therapeutics Sales by Region
6.1.1 APAC Plasma Protein Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Plasma Protein Therapeutics Revenue by Region (2020-2025)
6.2 APAC Plasma Protein Therapeutics Sales by Type (2020-2025)
6.3 APAC Plasma Protein Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma Protein Therapeutics by Country
7.1.1 Europe Plasma Protein Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Plasma Protein Therapeutics Revenue by Country (2020-2025)
7.2 Europe Plasma Protein Therapeutics Sales by Type (2020-2025)
7.3 Europe Plasma Protein Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma Protein Therapeutics by Country
8.1.1 Middle East & Africa Plasma Protein Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Plasma Protein Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Plasma Protein Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics
10.3 Manufacturing Process Analysis of Plasma Protein Therapeutics
10.4 Industry Chain Structure of Plasma Protein Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Protein Therapeutics Distributors
11.3 Plasma Protein Therapeutics Customer
12 WORLD FORECAST REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Plasma Protein Therapeutics Market Size Forecast by Region
12.1.1 Global Plasma Protein Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Plasma Protein Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Plasma Protein Therapeutics Forecast by Type (2026-2031)
12.7 Global Plasma Protein Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma Protein Therapeutics Product Portfolios and Specifications
13.1.3 Takeda Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Protein Therapeutics Product Portfolios and Specifications
13.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
13.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
13.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
13.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
13.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
13.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Protein Therapeutics Product Portfolios and Specifications
13.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
13.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
13.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Tiantan Bio
13.12.1 Tiantan Bio Company Information
13.12.2 Tiantan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.12.3 Tiantan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Tiantan Bio Main Business Overview
13.12.5 Tiantan Bio Latest Developments
13.13 Shuanglin Bio
13.13.1 Shuanglin Bio Company Information
13.13.2 Shuanglin Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.13.3 Shuanglin Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shuanglin Bio Main Business Overview
13.13.5 Shuanglin Bio Latest Developments
13.14 Boya Bio
13.14.1 Boya Bio Company Information
13.14.2 Boya Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.14.3 Boya Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Boya Bio Main Business Overview
13.14.5 Boya Bio Latest Developments
13.15 Yuanda Shuyang
13.15.1 Yuanda Shuyang Company Information
13.15.2 Yuanda Shuyang Plasma Protein Therapeutics Product Portfolios and Specifications
13.15.3 Yuanda Shuyang Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Yuanda Shuyang Main Business Overview
13.15.5 Yuanda Shuyang Latest Developments
13.16 Weiguang Bio
13.16.1 Weiguang Bio Company Information
13.16.2 Weiguang Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.16.3 Weiguang Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Weiguang Bio Main Business Overview
13.16.5 Weiguang Bio Latest Developments
13.17 Nanyue Bio
13.17.1 Nanyue Bio Company Information
13.17.2 Nanyue Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.17.3 Nanyue Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Nanyue Bio Main Business Overview
13.17.5 Nanyue Bio Latest Developments
13.18 KM Biologics
13.18.1 KM Biologics Company Information
13.18.2 KM Biologics Plasma Protein Therapeutics Product Portfolios and Specifications
13.18.3 KM Biologics Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 KM Biologics Main Business Overview
13.18.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plasma Protein Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Plasma Protein Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Plasma Protein Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Plasma Protein Therapeutics Segment by Type
2.2.1 Coagulation Factor
2.2.2 Immune Globulin
2.2.3 Albumin
2.2.4 Others
2.3 Plasma Protein Therapeutics Sales by Type
2.3.1 Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2020-2025)
2.4 Plasma Protein Therapeutics Segment by Application
2.4.1 Hemophilia
2.4.2 PID
2.4.3 Others
2.5 Plasma Protein Therapeutics Sales by Application
2.5.1 Global Plasma Protein Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Plasma Protein Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Plasma Protein Therapeutics Breakdown Data by Company
3.1.1 Global Plasma Protein Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Plasma Protein Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Plasma Protein Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Plasma Protein Therapeutics Sale Price by Company
3.4 Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Protein Therapeutics Product Location Distribution
3.4.2 Players Plasma Protein Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Plasma Protein Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Plasma Protein Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Plasma Protein Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Plasma Protein Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Plasma Protein Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Plasma Protein Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Plasma Protein Therapeutics Sales Growth
4.4 APAC Plasma Protein Therapeutics Sales Growth
4.5 Europe Plasma Protein Therapeutics Sales Growth
4.6 Middle East & Africa Plasma Protein Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Plasma Protein Therapeutics Sales by Country
5.1.1 Americas Plasma Protein Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Plasma Protein Therapeutics Revenue by Country (2020-2025)
5.2 Americas Plasma Protein Therapeutics Sales by Type (2020-2025)
5.3 Americas Plasma Protein Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma Protein Therapeutics Sales by Region
6.1.1 APAC Plasma Protein Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Plasma Protein Therapeutics Revenue by Region (2020-2025)
6.2 APAC Plasma Protein Therapeutics Sales by Type (2020-2025)
6.3 APAC Plasma Protein Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Plasma Protein Therapeutics by Country
7.1.1 Europe Plasma Protein Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Plasma Protein Therapeutics Revenue by Country (2020-2025)
7.2 Europe Plasma Protein Therapeutics Sales by Type (2020-2025)
7.3 Europe Plasma Protein Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plasma Protein Therapeutics by Country
8.1.1 Middle East & Africa Plasma Protein Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Plasma Protein Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Plasma Protein Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics
10.3 Manufacturing Process Analysis of Plasma Protein Therapeutics
10.4 Industry Chain Structure of Plasma Protein Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma Protein Therapeutics Distributors
11.3 Plasma Protein Therapeutics Customer
12 WORLD FORECAST REVIEW FOR PLASMA PROTEIN THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Plasma Protein Therapeutics Market Size Forecast by Region
12.1.1 Global Plasma Protein Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Plasma Protein Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Plasma Protein Therapeutics Forecast by Type (2026-2031)
12.7 Global Plasma Protein Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma Protein Therapeutics Product Portfolios and Specifications
13.1.3 Takeda Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Plasma Protein Therapeutics Product Portfolios and Specifications
13.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
13.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
13.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
13.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
13.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
13.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Plasma Protein Therapeutics Product Portfolios and Specifications
13.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
13.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
13.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Tiantan Bio
13.12.1 Tiantan Bio Company Information
13.12.2 Tiantan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.12.3 Tiantan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Tiantan Bio Main Business Overview
13.12.5 Tiantan Bio Latest Developments
13.13 Shuanglin Bio
13.13.1 Shuanglin Bio Company Information
13.13.2 Shuanglin Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.13.3 Shuanglin Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shuanglin Bio Main Business Overview
13.13.5 Shuanglin Bio Latest Developments
13.14 Boya Bio
13.14.1 Boya Bio Company Information
13.14.2 Boya Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.14.3 Boya Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Boya Bio Main Business Overview
13.14.5 Boya Bio Latest Developments
13.15 Yuanda Shuyang
13.15.1 Yuanda Shuyang Company Information
13.15.2 Yuanda Shuyang Plasma Protein Therapeutics Product Portfolios and Specifications
13.15.3 Yuanda Shuyang Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Yuanda Shuyang Main Business Overview
13.15.5 Yuanda Shuyang Latest Developments
13.16 Weiguang Bio
13.16.1 Weiguang Bio Company Information
13.16.2 Weiguang Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.16.3 Weiguang Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Weiguang Bio Main Business Overview
13.16.5 Weiguang Bio Latest Developments
13.17 Nanyue Bio
13.17.1 Nanyue Bio Company Information
13.17.2 Nanyue Bio Plasma Protein Therapeutics Product Portfolios and Specifications
13.17.3 Nanyue Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Nanyue Bio Main Business Overview
13.17.5 Nanyue Bio Latest Developments
13.18 KM Biologics
13.18.1 KM Biologics Company Information
13.18.2 KM Biologics Plasma Protein Therapeutics Product Portfolios and Specifications
13.18.3 KM Biologics Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 KM Biologics Main Business Overview
13.18.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Others
Table 7. Global Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Table 9. Global Plasma Protein Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2020-2025)
Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Plasma Protein Therapeutics Sale by Application (2020-2025) & (K Units)
Table 13. Global Plasma Protein Therapeutics Sale Market Share by Application (2020-2025)
Table 14. Global Plasma Protein Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2020-2025)
Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Plasma Protein Therapeutics Sales by Company (2020-2025) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2025)
Table 19. Global Plasma Protein Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2025)
Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Plasma Protein Therapeutics Products Offered
Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)
Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2020-2025)
Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 39. Americas Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 40. APAC Plasma Protein Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. APAC Plasma Protein Therapeutics Sales Market Share by Region (2020-2025)
Table 42. APAC Plasma Protein Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 44. APAC Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 45. Europe Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Plasma Protein Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 48. Europe Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics
Table 54. Key Market Challenges & Risks of Plasma Protein Therapeutics
Table 55. Key Industry Trends of Plasma Protein Therapeutics
Table 56. Plasma Protein Therapeutics Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Plasma Protein Therapeutics Distributors List
Table 59. Plasma Protein Therapeutics Customer List
Table 60. Global Plasma Protein Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Plasma Protein Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Plasma Protein Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Plasma Protein Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Plasma Protein Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Plasma Protein Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Plasma Protein Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Plasma Protein Therapeutics Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Plasma Protein Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Plasma Protein Therapeutics Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Plasma Protein Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Takeda Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 75. Takeda Plasma Protein Therapeutics Product Portfolios and Specifications
Table 76. Takeda Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Takeda Main Business
Table 78. Takeda Latest Developments
Table 79. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 80. CSL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 81. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. CSL Main Business
Table 83. CSL Latest Developments
Table 84. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 85. Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
Table 86. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Grifols Main Business
Table 88. Grifols Latest Developments
Table 89. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 90. Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
Table 91. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Octapharma Main Business
Table 93. Octapharma Latest Developments
Table 94. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
Table 96. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Kedrion Main Business
Table 98. Kedrion Latest Developments
Table 99. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
Table 101. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. LFB Group Main Business
Table 103. LFB Group Latest Developments
Table 104. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
Table 106. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Biotest Main Business
Table 108. Biotest Latest Developments
Table 109. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 110. BPL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 111. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. BPL Main Business
Table 113. BPL Latest Developments
Table 114. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
Table 116. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. RAAS Main Business
Table 118. RAAS Latest Developments
Table 119. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
Table 121. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. CBPO Main Business
Table 123. CBPO Latest Developments
Table 124. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 125. Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 126. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hualan Bio Main Business
Table 128. Hualan Bio Latest Developments
Table 129. Tiantan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 130. Tiantan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 131. Tiantan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Tiantan Bio Main Business
Table 133. Tiantan Bio Latest Developments
Table 134. Shuanglin Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 135. Shuanglin Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 136. Shuanglin Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Shuanglin Bio Main Business
Table 138. Shuanglin Bio Latest Developments
Table 139. Boya Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 140. Boya Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 141. Boya Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Boya Bio Main Business
Table 143. Boya Bio Latest Developments
Table 144. Yuanda Shuyang Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 145. Yuanda Shuyang Plasma Protein Therapeutics Product Portfolios and Specifications
Table 146. Yuanda Shuyang Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Yuanda Shuyang Main Business
Table 148. Yuanda Shuyang Latest Developments
Table 149. Weiguang Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 150. Weiguang Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 151. Weiguang Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Weiguang Bio Main Business
Table 153. Weiguang Bio Latest Developments
Table 154. Nanyue Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 155. Nanyue Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 156. Nanyue Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Nanyue Bio Main Business
Table 158. Nanyue Bio Latest Developments
Table 159. KM Biologics Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 160. KM Biologics Plasma Protein Therapeutics Product Portfolios and Specifications
Table 161. KM Biologics Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. KM Biologics Main Business
Table 163. KM Biologics Latest Developments
Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Others
Table 7. Global Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Table 9. Global Plasma Protein Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2020-2025)
Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Plasma Protein Therapeutics Sale by Application (2020-2025) & (K Units)
Table 13. Global Plasma Protein Therapeutics Sale Market Share by Application (2020-2025)
Table 14. Global Plasma Protein Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2020-2025)
Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Plasma Protein Therapeutics Sales by Company (2020-2025) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2025)
Table 19. Global Plasma Protein Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2025)
Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Plasma Protein Therapeutics Products Offered
Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)
Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2020-2025)
Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 39. Americas Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 40. APAC Plasma Protein Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. APAC Plasma Protein Therapeutics Sales Market Share by Region (2020-2025)
Table 42. APAC Plasma Protein Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 44. APAC Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 45. Europe Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Plasma Protein Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 48. Europe Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics
Table 54. Key Market Challenges & Risks of Plasma Protein Therapeutics
Table 55. Key Industry Trends of Plasma Protein Therapeutics
Table 56. Plasma Protein Therapeutics Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Plasma Protein Therapeutics Distributors List
Table 59. Plasma Protein Therapeutics Customer List
Table 60. Global Plasma Protein Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Plasma Protein Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Plasma Protein Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Plasma Protein Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Plasma Protein Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Plasma Protein Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Plasma Protein Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Plasma Protein Therapeutics Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Plasma Protein Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Plasma Protein Therapeutics Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Plasma Protein Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Takeda Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 75. Takeda Plasma Protein Therapeutics Product Portfolios and Specifications
Table 76. Takeda Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Takeda Main Business
Table 78. Takeda Latest Developments
Table 79. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 80. CSL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 81. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. CSL Main Business
Table 83. CSL Latest Developments
Table 84. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 85. Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
Table 86. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Grifols Main Business
Table 88. Grifols Latest Developments
Table 89. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 90. Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
Table 91. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Octapharma Main Business
Table 93. Octapharma Latest Developments
Table 94. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
Table 96. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Kedrion Main Business
Table 98. Kedrion Latest Developments
Table 99. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
Table 101. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. LFB Group Main Business
Table 103. LFB Group Latest Developments
Table 104. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
Table 106. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Biotest Main Business
Table 108. Biotest Latest Developments
Table 109. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 110. BPL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 111. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. BPL Main Business
Table 113. BPL Latest Developments
Table 114. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
Table 116. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. RAAS Main Business
Table 118. RAAS Latest Developments
Table 119. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
Table 121. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. CBPO Main Business
Table 123. CBPO Latest Developments
Table 124. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 125. Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 126. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hualan Bio Main Business
Table 128. Hualan Bio Latest Developments
Table 129. Tiantan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 130. Tiantan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 131. Tiantan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Tiantan Bio Main Business
Table 133. Tiantan Bio Latest Developments
Table 134. Shuanglin Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 135. Shuanglin Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 136. Shuanglin Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Shuanglin Bio Main Business
Table 138. Shuanglin Bio Latest Developments
Table 139. Boya Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 140. Boya Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 141. Boya Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Boya Bio Main Business
Table 143. Boya Bio Latest Developments
Table 144. Yuanda Shuyang Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 145. Yuanda Shuyang Plasma Protein Therapeutics Product Portfolios and Specifications
Table 146. Yuanda Shuyang Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Yuanda Shuyang Main Business
Table 148. Yuanda Shuyang Latest Developments
Table 149. Weiguang Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 150. Weiguang Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 151. Weiguang Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Weiguang Bio Main Business
Table 153. Weiguang Bio Latest Developments
Table 154. Nanyue Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 155. Nanyue Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 156. Nanyue Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Nanyue Bio Main Business
Table 158. Nanyue Bio Latest Developments
Table 159. KM Biologics Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 160. KM Biologics Plasma Protein Therapeutics Product Portfolios and Specifications
Table 161. KM Biologics Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. KM Biologics Main Business
Table 163. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Plasma Protein Therapeutics
Figure 2. Plasma Protein Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Protein Therapeutics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Plasma Protein Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Plasma Protein Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Plasma Protein Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Plasma Protein Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Coagulation Factor
Figure 12. Product Picture of Immune Globulin
Figure 13. Product Picture of Albumin
Figure 14. Product Picture of Others
Figure 15. Global Plasma Protein Therapeutics Sales Market Share by Type in 2025
Figure 16. Global Plasma Protein Therapeutics Revenue Market Share by Type (2020-2025)
Figure 17. Plasma Protein Therapeutics Consumed in Hemophilia
Figure 18. Global Plasma Protein Therapeutics Market: Hemophilia (2020-2025) & (K Units)
Figure 19. Plasma Protein Therapeutics Consumed in PID
Figure 20. Global Plasma Protein Therapeutics Market: PID (2020-2025) & (K Units)
Figure 21. Plasma Protein Therapeutics Consumed in Others
Figure 22. Global Plasma Protein Therapeutics Market: Others (2020-2025) & (K Units)
Figure 23. Global Plasma Protein Therapeutics Sale Market Share by Application (2024)
Figure 24. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2025
Figure 25. Plasma Protein Therapeutics Sales by Company in 2025 (K Units)
Figure 26. Global Plasma Protein Therapeutics Sales Market Share by Company in 2025
Figure 27. Plasma Protein Therapeutics Revenue by Company in 2025 ($ millions)
Figure 28. Global Plasma Protein Therapeutics Revenue Market Share by Company in 2025
Figure 29. Global Plasma Protein Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 32. Americas Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 33. APAC Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 34. APAC Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 35. Europe Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 36. Europe Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 39. Americas Plasma Protein Therapeutics Sales Market Share by Country in 2025
Figure 40. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2020-2025)
Figure 41. Americas Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 42. Americas Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 43. United States Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Plasma Protein Therapeutics Sales Market Share by Region in 2025
Figure 48. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2020-2025)
Figure 49. APAC Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 50. APAC Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 51. China Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. India Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2025
Figure 59. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2020-2025)
Figure 60. Europe Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 61. Europe Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 62. Germany Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. France Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 70. Egypt Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2025
Figure 76. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 77. Industry Chain Structure of Plasma Protein Therapeutics
Figure 78. Channels of Distribution
Figure 79. Global Plasma Protein Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 80. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Plasma Protein Therapeutics
Figure 2. Plasma Protein Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma Protein Therapeutics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Plasma Protein Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Plasma Protein Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Plasma Protein Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Plasma Protein Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Coagulation Factor
Figure 12. Product Picture of Immune Globulin
Figure 13. Product Picture of Albumin
Figure 14. Product Picture of Others
Figure 15. Global Plasma Protein Therapeutics Sales Market Share by Type in 2025
Figure 16. Global Plasma Protein Therapeutics Revenue Market Share by Type (2020-2025)
Figure 17. Plasma Protein Therapeutics Consumed in Hemophilia
Figure 18. Global Plasma Protein Therapeutics Market: Hemophilia (2020-2025) & (K Units)
Figure 19. Plasma Protein Therapeutics Consumed in PID
Figure 20. Global Plasma Protein Therapeutics Market: PID (2020-2025) & (K Units)
Figure 21. Plasma Protein Therapeutics Consumed in Others
Figure 22. Global Plasma Protein Therapeutics Market: Others (2020-2025) & (K Units)
Figure 23. Global Plasma Protein Therapeutics Sale Market Share by Application (2024)
Figure 24. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2025
Figure 25. Plasma Protein Therapeutics Sales by Company in 2025 (K Units)
Figure 26. Global Plasma Protein Therapeutics Sales Market Share by Company in 2025
Figure 27. Plasma Protein Therapeutics Revenue by Company in 2025 ($ millions)
Figure 28. Global Plasma Protein Therapeutics Revenue Market Share by Company in 2025
Figure 29. Global Plasma Protein Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 32. Americas Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 33. APAC Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 34. APAC Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 35. Europe Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 36. Europe Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Plasma Protein Therapeutics Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Plasma Protein Therapeutics Revenue 2020-2025 ($ millions)
Figure 39. Americas Plasma Protein Therapeutics Sales Market Share by Country in 2025
Figure 40. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2020-2025)
Figure 41. Americas Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 42. Americas Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 43. United States Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Plasma Protein Therapeutics Sales Market Share by Region in 2025
Figure 48. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2020-2025)
Figure 49. APAC Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 50. APAC Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 51. China Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. India Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2025
Figure 59. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2020-2025)
Figure 60. Europe Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 61. Europe Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 62. Germany Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. France Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 70. Egypt Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Plasma Protein Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2025
Figure 76. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 77. Industry Chain Structure of Plasma Protein Therapeutics
Figure 78. Channels of Distribution
Figure 79. Global Plasma Protein Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 80. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2026-2031)
